Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Check-Cap Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Check-Cap Ltd market cap is $4.21M.
What is the 52-week high for Check-Cap Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Check-Cap Ltd 52 week high is $3.04 as of September 11, 2025.
What is the 52-week low for Check-Cap Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Check-Cap Ltd 52 week low is $0.56 as of September 11, 2025.
What is Check-Cap Ltd stock price today?
Check-Cap Ltd stock price today is $0.686.
What was Check-Cap Ltd stock price yesterday?
Check-Cap Ltd stock price yesterday was $0.72.
What is the 50-day moving average of Check-Cap Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Check-Cap Ltd 50-day moving average is $0.707.